In this study, S100A9 was not only upregulated in the depression group but also increased in cancer cell lines with NE/COR treatment as well as in tumor-bearing mice with chronic stress, which was consistent with previous researches (34–36). Here, S100A9 is linked to depressive symptom measurement.